Home>Topics>>Omeros Corporation's Stock Has Potential To Double This Year
Omeros Corporation's Stock Has Potential To Double This Year
Healthcare Sector and Stocks Analysis from Seeking Alpha
Mon, 18 Feb 2013
By Biomed Group : We wanted to share some thoughts about O meros ( OMER ) , our top pick in the biotechnology industry, which fell from its long- term highs and is currently vastly undervalued. Moreover, Omeros has not yet been discovered by most investors, and has fundamental catalysts in place ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.